Jefferies cuts PT after Australia's Monash IVF downgrades 2025 guidance

Monash IVF

21/05/2025 21:36

** Brokerage Jefferies trim price target on Australia's Monash IVF MVF.AX to A$1.25 per share from A$1.45 per share

** Monash on Tuesday, downgraded its FY25 underlying NPAT forecast to about A$27.5 million  ($17.69 million), from its previous forecast of A$30.0 million to A$31.0 million

** Believe this is in part due to the somewhat discretionary nature of IVF as well as MVF’s exposure to Victoria, a state  that is facing economic challenges - Jefferies

** Six of seven analysts rate the stock "buy" or higher, one "hold"; their median PT is A$1.17, according to data compiled by LSEG

** Stock has fallen 39.4% this year, as of last close

($1 = 1.5545 Australian dollars)

 (Reporting by Roshan Thomas in Bengaluru)

 ((Roshan.Thomas@thomsonreuters.com))